The Marque The Marque
Reshma’s Profile > News Archive

Reshma’s News Archive

The News Archive for Reshma Kewalramani

Reshma’s News Archive

The News Archive for Reshma Kewalramani

Reshma Kewalramani

CEO & President

Vertex Pharmaceuticals
Boston, MA, USA
18 Dec 2023 | Morningstar

Vertex to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8

Dr. Reshma Kewalramani, Chief Executive Officer and President of Vertex Pharmaceuticals, will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on 8 January 2024.

8 Dec 2023 | The Daily Mail

FDA approves world-first gene editing treatment: Sickle cell therapy gives hope to 100,000 Americans

Dr Reshma Kewalramani, CEO and President of Vertex Pharmaceuticals, described the approval of Casgevy by the Food and Drug Administration as 'momentous'. Casgevy alters the faulty gene that causes sickle cell disease and this results in the production of functioning hemoglobin in the body.

16 Nov 2023 | Good Word News

UK approves Vertex and CRISPR therapy for sickle cell disease and beta thalassemia in world first

Reshma Kewalramani, CEO of Vertex, has described Britain’s approval of Casgevy and the first regulatory approval of a CRISPR-based therapy in the world, as a historic day for medicine and science.

3 Nov 2023 | The Boston Globe

How a career pivot catapulted Vertex’s CEO to the top of the biotech world

Janelle Nanos tells the success story of Vertex Chief Executive Officer Reshma Kewalramani: from transplant nephrologist to heading biotech giant Vertex.

5 Oct 2023 | Boston University Medical Campus

Vertex CEO Reshma Kewalramani, MD’98, Receives 2023 Distinguished Alumni Award

Reshma Kewalramani, Vertex CEO, has been named as the 2023 recipient of the Distinguished Alumni Award from Boston University Medical Campus for her outstanding achievements in the fields of medicine, healthcare and biotechnology.

Load More